Yesterday's Wall Street Journal has an interesting article about the FDA's off-label promotion ban being "in some jeopardy" after the Supreme Court's Sorrell decision, and pointing to the Caronia case, to be decided "within weeks," as the leading example of possible First Amendment scrutiny. Well, you heard it here first. We pointed out this implication of Sorrell back in June, the day that the Supreme Court decided the case. We've been following Caronia even longer. Glad to see the mainstream media waking up, that the government ability to monetize (to the tune of over $8 billion, according to the article) its First Amendment violations may be drawing to a long-overdue close.
Please see article below.
Firefox recommends the PDF Plugin for Mac OS X for viewing PDF documents in your browser.
We can also show you Legal Updates using the Google Viewer; however, you will need to be logged into Google Docs to view them.
Please choose one of the above to proceed!
LOADING PDF: If there are any problems, click here to download the file.